MITORX THERAPEUTICS LIMITED

Active Oxford

Research and experimental development on biotechnology

9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther business support service activities n.e.c.
M

MITORX THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 2 Mar 2021 Active Oxford, United Kingdom 9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther business support service activities n.e.c.

Previous Company Names

IFFLEY BIOTECH LTD 2 Mar 2021 — 22 Jul 2021
Accounts Due 31 Dec 2026 6 months remaining
Confirmation Submitted 9 Mar 2026 Next due 15 Mar 2027 9 months remaining
Net assets £1M £73K 2024 year on year
Total assets £2M £49K 2024 year on year
Total Liabilities £217K £25K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

9400 Garsington Road Oxford Business Park Oxford OX4 2HN United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MITORX THERAPEUTICS LIMITED (13237941), an active life sciences and medical technology company based in Oxford, United Kingdom. Incorporated 2 Mar 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type total-exemption-full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£1.12M

Decreased by £125.52k (-10%)

Net Assets

£1.40M

Decreased by £73.43k (-5%)

Total Liabilities

£216.69k

Increased by £24.91k (+13%)

Turnover

N/A

Employees

9

Debt Ratio

13%

Increased by 1 (+8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (9)

Investor NameInvestor SinceParticipating Rounds
Investor 2Apr 2022Seed
Investor 5Apr 2022Seed
Investor 6Apr 2022Seed

Share Capital

Share Capital

Share allotments and capital structure

21 Allotments 7,589,420 Shares £13.08m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Dec 2025431,338£819k£1.899
18 Dec 2025427,436£811k£1.899
28 Nov 2025262,527£449k£1.709
28 Nov 2025301,406£515k£1.709
28 Nov 2025262,527£449k£1.709

Officers

Officers

3 active
Status
Cowling, Didier Shaun PhilipDirectorBritish,frenchSwitzerland6112 Nov 2025Active
Matthew Loren WhitemanDirectorBritishUnited Kingdom5422 Sept 2021Active
Norman Milne LawDirectorBritishEngland632 Mar 2021Active

Shareholders

Shareholders (105)

Oshen Holdings Sa
16.6%
2,106,926
University Of Exeter
7.0%
885,700

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Jonathan David Rees

Ceased 25 Jan 2022

Ceased

Norman Milne Law

Ceased 25 Jan 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 Apr 2026MiscellaneousReplacement filing of SH01 - 28/11/25 Statement of Capital gbp 958.122
14 Apr 2026MiscellaneousReplacement filing of SH01 - 28/11/25 Statement of Capital gbp 908.1721
19 Mar 2026OfficersAppointment of Mr Mohammad Sohail Fazeli as director on 17 Mar 2026
9 Mar 2026Confirmation StatementConfirmation statement made on 1 Mar 2026 with updates
22 Jan 2026ResolutionResolutions
14 Apr 2026 Miscellaneous

Replacement filing of SH01 - 28/11/25 Statement of Capital gbp 958.122

14 Apr 2026 Miscellaneous

Replacement filing of SH01 - 28/11/25 Statement of Capital gbp 908.1721

19 Mar 2026 Officers

Appointment of Mr Mohammad Sohail Fazeli as director on 17 Mar 2026

9 Mar 2026 Confirmation Statement

Confirmation statement made on 1 Mar 2026 with updates

22 Jan 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Replacement filing of SH01 - 28/11/25 Statement of Capital gbp 958.122

1 months ago on 14 Apr 2026

Replacement filing of SH01 - 28/11/25 Statement of Capital gbp 908.1721

1 months ago on 14 Apr 2026

Appointment of Mr Mohammad Sohail Fazeli as director on 17 Mar 2026

2 months ago on 19 Mar 2026

Confirmation statement made on 1 Mar 2026 with updates

3 months ago on 9 Mar 2026

Resolutions

4 months ago on 22 Jan 2026